Codify — Article

BEACON Act of 2026 funds VA grants for chronic mild TBI neurorehabilitation research

Mandates two VA grant streams and an independent research hub to develop, test, and validate non‑pharmacological and integrated treatments for veterans with chronic mild traumatic brain injury.

The Brief

The BEACON Act of 2026 directs the Secretary of Veterans Affairs to create and run grant programs to develop, test, and evaluate neurorehabilitation treatments for chronic mild traumatic brain injury (mTBI) in veterans. It emphasizes prospective randomized controlled trials, clinician training, community partnerships, and integration with VA mental health efforts.

The bill targets gaps in treatment options and evidence for mTBI by funding pilot innovation projects, applied third‑party research, and mechanisms to translate validated interventions into practice within and beyond traditional VA care pathways. It requires oversight, annual evaluation, and reporting to inform whether the programs should continue or scale.

At a Glance

What It Does

Requires the VA to run two grant programs: an innovation stream to design and pilot prospective randomized controlled trials of neurorehabilitation approaches for chronic mTBI, and a research stream administered or overseen by an independent third party to validate, synthesize, and recommend standards of care. Grants must support clinical studies, clinician training, outreach, and partnerships for implementation and evaluation.

Who It Affects

Affects nonprofit organizations, academic institutions conducting TBI research, non‑VA health care providers with neurorehabilitation expertise, and other VA partners that apply for grants. It also shapes work for an independent third‑party research organization tasked with administering grant awards and producing aggregated study findings.

Why It Matters

Creates a targeted federal funding window for intervention development and validation where clinical evidence is thin, and builds procedural hooks — reporting, evaluations, and VA coordination — designed to accelerate translation of effective mTBI treatments into veteran care pathways.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The BEACON Act establishes two complementary VA grant authorities focused on chronic mild traumatic brain injury in veterans. The first creates the "TBI Innovation Grant Program" to support eligible entities in designing and running prospective randomized controlled trials and other studies of novel or integrative neurorehabilitation treatments.

That stream also funds clinician training, veteran and family outreach, and partnerships to implement and assess best practices.

Eligible applicants for the innovation stream include nonprofits, academic institutions, non‑VA health care providers with neurorehabilitation expertise, and any other entity the Secretary finds appropriate. The Secretary must set application requirements, require annual reporting on use of funds and measured outcomes, and conduct annual evaluations and oversight of funded activities.

The Secretary is required to align this stream with the VA's Staff Sergeant Fox Suicide Prevention Grant Program to address overlapping mental health needs tied to mTBI.The second authority funds a research grant program for independent third‑party studies and applied programs. The Secretary must enter into an agreement with an independent organization (modeled on the VA's National Center for PTSD) to administer the program, perform randomized controlled trials, analyze data from funded projects, identify evidence‑based best practices, and produce a comprehensive report with recommendations to Congress and the Secretary.

This stream is structured to fund both exploratory pilot projects and larger collaborative, multidisciplinary initiatives.Practical mechanics built into the bill include grant application and reporting requirements, limits on individual grant awards in the innovation stream, explicit grant categories and award numbers in the research stream, a requirement that the Secretary promulgate regulations within 180 days of enactment, and a built‑in three‑year authorization window after which the authorities expire unless extended. The statutes direct ongoing evaluation during the authorization period so VA can determine whether to continue or expand the programs based on outcome data and implementation experience.

The Five Things You Need to Know

1

Section 2 caps awards from the TBI Innovation Grant Program at $5,000,000 per eligible entity per fiscal year.

2

Section 3 requires the Secretary to award, each fiscal year, four exploratory pilot grants (up to $625,000 each) and five collaborative multidisciplinary grants (up to $1,500,000 each).

3

The bill authorizes $30 million for the innovation pilot program (section 2) across fiscal years 2026–2028 and $10 million per year for fiscal years 2026–2028 for the research program (section 3).

4

The Secretary must issue implementing regulations within 180 days of enactment and the grant authorities automatically terminate three years after enactment unless renewed.

5

An independent third‑party organization must administer the research program, run randomized controlled trials and analyses, and deliver a comprehensive report with recommendations to Congress and the Secretary.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 2

TBI Innovation Grant Program for prospective RCTs and implementation

This section creates the TBI Innovation Grant Program and lists eligible applicants: nonprofits, academic institutions, non‑VA health care providers with neurorehabilitation expertise, and other entities the Secretary designates. It specifies allowable uses—designing and testing novel or integrative treatments (including non‑pharmacological therapies), conducting clinical effectiveness studies, clinician training, outreach, and building community‑VA partnerships for implementation. Practically, this provision sets the scope for pilot projects that combine clinical research with implementation activities and requires grantees to submit annual reports on activities and measured outcomes.

Section 2(d–f, g, h)

Grant limits, priorities, oversight, VA coordination, and rulemaking

The Secretary may not award more than $5,000,000 to any single grantee in a fiscal year under the innovation program and must prioritize applicants with demonstrated experience treating mTBI. The statute requires application standards, annual grantee reporting, and the Secretary’s annual program evaluations. It also directs the Secretary to align this innovation stream with the VA’s Staff Sergeant Fox Suicide Prevention Grant Program to ensure integrated care for mTBI and associated mental health conditions. The Secretary must promulgate implementing regulations within 180 days.

Section 3

Research grant program and independent third‑party administration

Section 3 establishes a separate research grant program and mandates an agreement with an independent third‑party organization to administer the program and carry out synthesis and validation activities. The Secretary allocates two grant categories annually—smaller exploratory grants and larger collaborative grants—with a statutory minimum number of awards and a requirement that at least three exploratory grants go to nonprofits. The third party’s role includes conducting randomized controlled trials, aggregating data from funded projects, identifying evidence‑based practices, and reporting findings and care recommendations to Congress and VA leadership.

2 more sections
Section 3(f–g)

Funding sources, appropriations language, and congressional reporting

The bill authorizes specific appropriations for each grant stream and permits the Secretary to use certain existing VA funds (for general mental health programs or the operating budget of the National Center for PTSD) as allowable sources. The research program requires the independent third party to submit comprehensive findings and recommendations, and the Secretary must report annually to Congress on study findings and policy recommendations during the three‑year authority period.

Section 4

Definitions

This brief definitions section clarifies key terms used in the Act: 'TBI' (traumatic brain injury), 'treatment' (clinical interventions, therapeutic devices, or rehabilitation care provided directly to a veteran with TBI), and 'veteran' (as defined in 38 U.S.C. §101). These definitions set the perimeter for who is eligible to participate in studies and what interventions count as funded treatments.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Veterans with chronic mild TBI — stand to gain access to validated, possibly non‑pharmacological neurorehabilitation therapies and expanded care options, plus outreach and clinician training aimed at improving access and uptake.
  • Academic researchers and clinical investigators — receive new, targeted federal grant opportunities for prospective RCTs and multidisciplinary collaborations, including chances to partner with an independent research hub for larger validation studies.
  • Nonprofit treatment and advocacy organizations — can obtain pilot and exploratory funding to develop community‑based interventions and receive priority in certain award categories, improving capacity to deliver or test novel care models.
  • Non‑VA neurorehabilitation providers — become eligible grant recipients and implementation partners, increasing pathways to deliver validated treatments outside traditional VA clinical structures.

Who Bears the Cost

  • Department of Veterans Affairs — tasked with program administration, oversight, regulation drafting within 180 days, annual evaluations, and coordination with existing suicide prevention efforts, which will consume staff time and resources if not separately funded.
  • Independent third‑party organization — responsible for program administration, running RCTs, data aggregation, and delivering congressional reports, which requires capacity, expertise, and likely sustained funding and staffing commitments.
  • Grantee organizations — face administrative burdens from required reporting, prescribed evaluation metrics, and the need to meet rigorous trial standards; smaller groups may need to build research infrastructure to compete.
  • Congress and appropriators — will decide whether to provide the authorized funding and may face requests to continue or expand the programs after the three‑year pilot, potentially creating future budgetary pressures.

Key Issues

The Core Tension

The central dilemma is whether a three‑year, pilot‑style funding window can produce the high‑quality, generalizable randomized controlled trial evidence and implementation lessons needed to change care for veterans with chronic mTBI, without diverting scarce VA mental health research resources or imposing unrealistic timelines on rigorous clinical science.

The bill tightly couples innovation and validation under VA auspices but leaves several operational choices to the Secretary that will shape outcomes. It authorizes discrete sums but requires the Secretary to draw on existing mental health or National Center for PTSD budgets if appropriations lag, which risks diverting resources from ongoing programs.

The statutory grant cap in the innovation stream ($5 million per grantee) and the delineated award counts and sizes in the research stream create predictable award structures, yet they may not map cleanly to the true cost of large, multicenter randomized trials or long‑term implementation studies.

Implementation also hinges on the independent third‑party’s capacity and on how rigorously the Secretary enforces reporting and evaluation standards. The requirement to align with the Staff Sergeant Fox Suicide Prevention Grant Program is sensible in principle, but operational integration across VA programs—data sharing, referral pathways, and clinical credentialing—can be complex.

Finally, the three‑year authorization and the mandate for an annual review create a short window to demonstrate meaningful clinical outcomes for interventions (many of which require long follow‑up), raising tension between producing quick, publishable results and generating durable evidence for standard‑of‑care change.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.